nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN8A—cerebellar cortex—Parkinson's disease	0.0705	0.112	CbGeAlD
Phenazopyridine—SCN11A—peripheral nervous system—Parkinson's disease	0.0437	0.0696	CbGeAlD
Phenazopyridine—SCN11A—nerve—Parkinson's disease	0.0341	0.0542	CbGeAlD
Phenazopyridine—SCN8A—peripheral nervous system—Parkinson's disease	0.0332	0.0527	CbGeAlD
Phenazopyridine—SCN8A—nerve—Parkinson's disease	0.0258	0.0411	CbGeAlD
Phenazopyridine—SCN10A—peripheral nervous system—Parkinson's disease	0.0222	0.0353	CbGeAlD
Phenazopyridine—SCN8A—hindbrain—Parkinson's disease	0.0194	0.0308	CbGeAlD
Phenazopyridine—SCN10A—nerve—Parkinson's disease	0.0173	0.0275	CbGeAlD
Phenazopyridine—SCN1A—hindbrain—Parkinson's disease	0.0146	0.0233	CbGeAlD
Phenazopyridine—SCN2A—hindbrain—Parkinson's disease	0.0134	0.0214	CbGeAlD
Phenazopyridine—SCN8A—brainstem—Parkinson's disease	0.0111	0.0176	CbGeAlD
Phenazopyridine—SCN8A—forebrain—Parkinson's disease	0.0107	0.017	CbGeAlD
Phenazopyridine—SCN7A—cardiovascular system—Parkinson's disease	0.0102	0.0162	CbGeAlD
Phenazopyridine—SCN7A—L1CAM interactions—DLG1—Parkinson's disease	0.00958	0.0258	CbGpPWpGaD
Phenazopyridine—SCN11A—spinal cord—Parkinson's disease	0.0091	0.0145	CbGeAlD
Phenazopyridine—SCN11A—L1CAM interactions—DLG1—Parkinson's disease	0.00854	0.023	CbGpPWpGaD
Phenazopyridine—SCN1A—brainstem—Parkinson's disease	0.00839	0.0133	CbGeAlD
Phenazopyridine—SCN1A—forebrain—Parkinson's disease	0.0081	0.0129	CbGeAlD
Phenazopyridine—SCN11A—head—Parkinson's disease	0.00809	0.0129	CbGeAlD
Phenazopyridine—SCN8A—L1CAM interactions—DLG1—Parkinson's disease	0.00781	0.021	CbGpPWpGaD
Phenazopyridine—SCN2A—brainstem—Parkinson's disease	0.0077	0.0122	CbGeAlD
Phenazopyridine—SCN11A—nervous system—Parkinson's disease	0.00767	0.0122	CbGeAlD
Phenazopyridine—SCN2A—forebrain—Parkinson's disease	0.00743	0.0118	CbGeAlD
Phenazopyridine—SCN11A—central nervous system—Parkinson's disease	0.00739	0.0117	CbGeAlD
Phenazopyridine—SCN10A—forebrain—Parkinson's disease	0.00716	0.0114	CbGeAlD
Phenazopyridine—SCN8A—spinal cord—Parkinson's disease	0.0069	0.011	CbGeAlD
Phenazopyridine—SCN7A—head—Parkinson's disease	0.00688	0.0109	CbGeAlD
Phenazopyridine—SCN3A—forebrain—Parkinson's disease	0.00653	0.0104	CbGeAlD
Phenazopyridine—SCN9A—L1CAM interactions—DLG1—Parkinson's disease	0.00632	0.017	CbGpPWpGaD
Phenazopyridine—SCN9A—midbrain—Parkinson's disease	0.00621	0.00988	CbGeAlD
Phenazopyridine—SCN8A—head—Parkinson's disease	0.00613	0.00975	CbGeAlD
Phenazopyridine—SCN9A—spinal cord—Parkinson's disease	0.00606	0.00964	CbGeAlD
Phenazopyridine—SCN3A—L1CAM interactions—DLG1—Parkinson's disease	0.00604	0.0163	CbGpPWpGaD
Phenazopyridine—SCN11A—brain—Parkinson's disease	0.00586	0.00933	CbGeAlD
Phenazopyridine—SCN1A—medulla oblongata—Parkinson's disease	0.00585	0.0093	CbGeAlD
Phenazopyridine—SCN8A—nervous system—Parkinson's disease	0.00581	0.00925	CbGeAlD
Phenazopyridine—SCN2A—L1CAM interactions—DLG1—Parkinson's disease	0.00581	0.0156	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—DLG1—Parkinson's disease	0.00581	0.0156	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—NRTN—Parkinson's disease	0.0058	0.0156	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—DLG1—Parkinson's disease	0.0056	0.0151	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—DLG1—Parkinson's disease	0.0056	0.0151	CbGpPWpGaD
Phenazopyridine—SCN8A—central nervous system—Parkinson's disease	0.0056	0.0089	CbGeAlD
Phenazopyridine—SCN5A—cardiovascular system—Parkinson's disease	0.00551	0.00876	CbGeAlD
Phenazopyridine—SCN8A—cerebellum—Parkinson's disease	0.00547	0.0087	CbGeAlD
Phenazopyridine—SCN2A—medulla oblongata—Parkinson's disease	0.00537	0.00854	CbGeAlD
Phenazopyridine—SCN1A—midbrain—Parkinson's disease	0.00535	0.0085	CbGeAlD
Phenazopyridine—SCN1A—spinal cord—Parkinson's disease	0.00522	0.0083	CbGeAlD
Phenazopyridine—SCN11A—Axon guidance—NRTN—Parkinson's disease	0.00517	0.0139	CbGpPWpGaD
Phenazopyridine—SCN7A—brain—Parkinson's disease	0.00499	0.00793	CbGeAlD
Phenazopyridine—SCN2A—midbrain—Parkinson's disease	0.00491	0.0078	CbGeAlD
Phenazopyridine—SCN4A—head—Parkinson's disease	0.00481	0.00765	CbGeAlD
Phenazopyridine—SCN2A—spinal cord—Parkinson's disease	0.00479	0.00761	CbGeAlD
Phenazopyridine—SCN8A—Axon guidance—NRTN—Parkinson's disease	0.00473	0.0127	CbGpPWpGaD
Phenazopyridine—SCN3A—medulla oblongata—Parkinson's disease	0.00472	0.0075	CbGeAlD
Phenazopyridine—SCN1A—head—Parkinson's disease	0.00464	0.00737	CbGeAlD
Phenazopyridine—SCN10A—spinal cord—Parkinson's disease	0.00462	0.00734	CbGeAlD
Phenazopyridine—SCN4A—nervous system—Parkinson's disease	0.00456	0.00725	CbGeAlD
Phenazopyridine—SCN7A—L1CAM interactions—HSPA8—Parkinson's disease	0.00448	0.0121	CbGpPWpGaD
Phenazopyridine—SCN8A—brain—Parkinson's disease	0.00444	0.00707	CbGeAlD
Phenazopyridine—SCN1A—nervous system—Parkinson's disease	0.00439	0.00699	CbGeAlD
Phenazopyridine—SCN4A—central nervous system—Parkinson's disease	0.00439	0.00698	CbGeAlD
Phenazopyridine—SCN3A—midbrain—Parkinson's disease	0.00431	0.00686	CbGeAlD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00428	0.0115	CbGpPWpGaD
Phenazopyridine—SCN2A—head—Parkinson's disease	0.00425	0.00677	CbGeAlD
Phenazopyridine—SCN1A—central nervous system—Parkinson's disease	0.00423	0.00673	CbGeAlD
Phenazopyridine—SCN3A—spinal cord—Parkinson's disease	0.00421	0.00669	CbGeAlD
Phenazopyridine—SCN7A—L1CAM interactions—DLG4—Parkinson's disease	0.0042	0.0113	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—NRTN—Parkinson's disease	0.00414	0.0112	CbGpPWpGaD
Phenazopyridine—SCN1A—cerebellum—Parkinson's disease	0.00414	0.00658	CbGeAlD
Phenazopyridine—SCN10A—head—Parkinson's disease	0.0041	0.00653	CbGeAlD
Phenazopyridine—SCN2A—nervous system—Parkinson's disease	0.00403	0.00642	CbGeAlD
Phenazopyridine—SCN11A—L1CAM interactions—HSPA8—Parkinson's disease	0.00399	0.0108	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—DLG1—Parkinson's disease	0.00394	0.0106	CbGpPWpGaD
Phenazopyridine—SCN9A—brain—Parkinson's disease	0.0039	0.00621	CbGeAlD
Phenazopyridine—SCN10A—nervous system—Parkinson's disease	0.00389	0.00619	CbGeAlD
Phenazopyridine—SCN2A—central nervous system—Parkinson's disease	0.00388	0.00618	CbGeAlD
Phenazopyridine—SCN9A—Axon guidance—NRTN—Parkinson's disease	0.00383	0.0103	CbGpPWpGaD
Phenazopyridine—SCN2A—cerebellum—Parkinson's disease	0.0038	0.00604	CbGeAlD
Phenazopyridine—SCN11A—L1CAM interactions—DLG4—Parkinson's disease	0.00375	0.0101	CbGpPWpGaD
Phenazopyridine—SCN10A—central nervous system—Parkinson's disease	0.00374	0.00596	CbGeAlD
Phenazopyridine—SCN3A—head—Parkinson's disease	0.00374	0.00595	CbGeAlD
Phenazopyridine—SCN5A—head—Parkinson's disease	0.00373	0.00593	CbGeAlD
Phenazopyridine—SCN11A—Developmental Biology—NRTN—Parkinson's disease	0.00369	0.00994	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—NRTN—Parkinson's disease	0.00366	0.00986	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—HSPA8—Parkinson's disease	0.00365	0.00984	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—DLG1—Parkinson's disease	0.00362	0.00975	CbGpPWpGaD
Phenazopyridine—SCN3A—nervous system—Parkinson's disease	0.00354	0.00564	CbGeAlD
Phenazopyridine—SCN5A—nervous system—Parkinson's disease	0.00353	0.00562	CbGeAlD
Phenazopyridine—SCN2A—Axon guidance—NRTN—Parkinson's disease	0.00352	0.00947	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—NRTN—Parkinson's disease	0.00352	0.00947	CbGpPWpGaD
Phenazopyridine—SCN4A—brain—Parkinson's disease	0.00348	0.00554	CbGeAlD
Phenazopyridine—SCN8A—L1CAM interactions—DLG4—Parkinson's disease	0.00343	0.00923	CbGpPWpGaD
Phenazopyridine—SCN3A—central nervous system—Parkinson's disease	0.00341	0.00543	CbGeAlD
Phenazopyridine—SCN5A—central nervous system—Parkinson's disease	0.0034	0.00541	CbGeAlD
Phenazopyridine—SCN1A—Axon guidance—NRTN—Parkinson's disease	0.00339	0.00913	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—NRTN—Parkinson's disease	0.00339	0.00913	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NRTN—Parkinson's disease	0.00338	0.00909	CbGpPWpGaD
Phenazopyridine—SCN1A—brain—Parkinson's disease	0.00336	0.00534	CbGeAlD
Phenazopyridine—SCN3A—cerebellum—Parkinson's disease	0.00334	0.00531	CbGeAlD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00324	0.00873	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—DLG1—Parkinson's disease	0.00323	0.00869	CbGpPWpGaD
Phenazopyridine—SCN2A—brain—Parkinson's disease	0.00308	0.0049	CbGeAlD
Phenazopyridine—SCN10A—brain—Parkinson's disease	0.00297	0.00473	CbGeAlD
Phenazopyridine—SCN9A—L1CAM interactions—HSPA8—Parkinson's disease	0.00295	0.00796	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—DLG1—Parkinson's disease	0.00295	0.00795	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—GDNF—Parkinson's disease	0.00283	0.00763	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—HSPA8—Parkinson's disease	0.00283	0.00761	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—DLG4—Parkinson's disease	0.00277	0.00747	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NRTN—Parkinson's disease	0.00273	0.00735	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—HSPA8—Parkinson's disease	0.00271	0.00731	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—HSPA8—Parkinson's disease	0.00271	0.00731	CbGpPWpGaD
Phenazopyridine—SCN3A—brain—Parkinson's disease	0.00271	0.00431	CbGeAlD
Phenazopyridine—SCN5A—brain—Parkinson's disease	0.0027	0.0043	CbGeAlD
Phenazopyridine—SCN3A—L1CAM interactions—DLG4—Parkinson's disease	0.00265	0.00714	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—HSPA8—Parkinson's disease	0.00262	0.00705	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—HSPA8—Parkinson's disease	0.00262	0.00705	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—NRTN—Parkinson's disease	0.00261	0.00703	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—DLG1—Parkinson's disease	0.00258	0.00696	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—DLG4—Parkinson's disease	0.00255	0.00686	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—DLG4—Parkinson's disease	0.00255	0.00686	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—GDNF—Parkinson's disease	0.00253	0.0068	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NRTN—Parkinson's disease	0.00251	0.00676	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NRTN—Parkinson's disease	0.00251	0.00676	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—DLG4—Parkinson's disease	0.00246	0.00661	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—DLG4—Parkinson's disease	0.00246	0.00661	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NRTN—Parkinson's disease	0.00242	0.00652	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NRTN—Parkinson's disease	0.00242	0.00652	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—DLG1—Parkinson's disease	0.00239	0.00643	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—NRTN—Parkinson's disease	0.00238	0.00642	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—GDNF—Parkinson's disease	0.00231	0.00622	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—DLG1—Parkinson's disease	0.0023	0.0062	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—DLG1—Parkinson's disease	0.00228	0.00615	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—IGF2—Parkinson's disease	0.0022	0.00593	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—DLG1—Parkinson's disease	0.00219	0.00591	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—DLG1—Parkinson's disease	0.00219	0.00591	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—DLG1—Parkinson's disease	0.00212	0.0057	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—DLG1—Parkinson's disease	0.00212	0.0057	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—DLG1—Parkinson's disease	0.00211	0.00567	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00202	0.00545	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—GDNF—Parkinson's disease	0.00202	0.00545	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—GDNF—Parkinson's disease	0.00187	0.00503	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—HSPA8—Parkinson's disease	0.00184	0.00496	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—GDNF—Parkinson's disease	0.0018	0.00485	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—GDNF—Parkinson's disease	0.00179	0.00481	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—DLG4—Parkinson's disease	0.00173	0.00465	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—GDNF—Parkinson's disease	0.00172	0.00462	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—GDNF—Parkinson's disease	0.00172	0.00462	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—DLG1—Parkinson's disease	0.0017	0.00459	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NRTN—Parkinson's disease	0.0017	0.00458	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—HSPA8—Parkinson's disease	0.00169	0.00456	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—GDNF—Parkinson's disease	0.00166	0.00446	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—GDNF—Parkinson's disease	0.00166	0.00446	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—GDNF—Parkinson's disease	0.00165	0.00444	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—DLG1—Parkinson's disease	0.00163	0.00439	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—DLG4—Parkinson's disease	0.00159	0.00428	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—DLG1—Parkinson's disease	0.00157	0.00422	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—DLG1—Parkinson's disease	0.00157	0.00422	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—GRIN2B—Parkinson's disease	0.00155	0.00418	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—DLG1—Parkinson's disease	0.00151	0.00407	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—DLG1—Parkinson's disease	0.00151	0.00407	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—HSPA8—Parkinson's disease	0.00151	0.00406	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—DLG1—Parkinson's disease	0.00149	0.00401	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—INS—Parkinson's disease	0.00146	0.00394	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—DLG4—Parkinson's disease	0.00142	0.00381	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—GRIN2B—Parkinson's disease	0.00138	0.00373	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—HSPA8—Parkinson's disease	0.00138	0.00372	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00136	0.00367	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—GDNF—Parkinson's disease	0.00133	0.00359	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00131	0.00353	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—DLG4—Parkinson's disease	0.0013	0.00349	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00129	0.00348	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—GDNF—Parkinson's disease	0.00128	0.00343	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—ABL1—Parkinson's disease	0.00127	0.00341	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—GRIN2B—Parkinson's disease	0.00127	0.00341	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—GDNF—Parkinson's disease	0.00123	0.0033	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—GDNF—Parkinson's disease	0.00123	0.0033	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—HSPA8—Parkinson's disease	0.00121	0.00325	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—GDNF—Parkinson's disease	0.00118	0.00318	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—GDNF—Parkinson's disease	0.00118	0.00318	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—GDNF—Parkinson's disease	0.00116	0.00313	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—DLG4—Parkinson's disease	0.00113	0.00305	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—ABL1—Parkinson's disease	0.00113	0.00304	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00113	0.00304	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—HSPA8—Parkinson's disease	0.00112	0.00301	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—GRIN2B—Parkinson's disease	0.00111	0.00298	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—HSPA8—Parkinson's disease	0.00108	0.0029	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—HSPA8—Parkinson's disease	0.00107	0.00288	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—DLG1—Parkinson's disease	0.00106	0.00286	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—DLG4—Parkinson's disease	0.00105	0.00282	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—ABL1—Parkinson's disease	0.00103	0.00278	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—HSPA8—Parkinson's disease	0.00103	0.00276	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—HSPA8—Parkinson's disease	0.00103	0.00276	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—GRIN2B—Parkinson's disease	0.00102	0.00276	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—DLG4—Parkinson's disease	0.00101	0.00272	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—DLG4—Parkinson's disease	0.001	0.0027	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—HSPA8—Parkinson's disease	0.000989	0.00266	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—HSPA8—Parkinson's disease	0.000989	0.00266	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—GRIN2B—Parkinson's disease	0.000988	0.00266	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—HSPA8—Parkinson's disease	0.000985	0.00265	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—GRIN2B—Parkinson's disease	0.000979	0.00264	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—DLG4—Parkinson's disease	0.000963	0.00259	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—DLG4—Parkinson's disease	0.000963	0.00259	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000952	0.00256	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—GRIN2B—Parkinson's disease	0.000941	0.00253	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—GRIN2B—Parkinson's disease	0.000941	0.00253	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—DLG4—Parkinson's disease	0.000928	0.0025	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—DLG4—Parkinson's disease	0.000928	0.0025	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—DLG4—Parkinson's disease	0.000924	0.00249	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000919	0.00247	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—GRIN2B—Parkinson's disease	0.000907	0.00244	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—GRIN2B—Parkinson's disease	0.000907	0.00244	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—ABL1—Parkinson's disease	0.000903	0.00243	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—GRIN2B—Parkinson's disease	0.000903	0.00243	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—ABL1—Parkinson's disease	0.000835	0.00225	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—GDNF—Parkinson's disease	0.000831	0.00224	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000816	0.0022	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—ABL1—Parkinson's disease	0.000805	0.00217	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—ABL1—Parkinson's disease	0.000798	0.00215	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—HSPA8—Parkinson's disease	0.000797	0.00215	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000776	0.00209	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—ABL1—Parkinson's disease	0.000767	0.00207	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—ABL1—Parkinson's disease	0.000767	0.00207	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HSPA8—Parkinson's disease	0.000762	0.00205	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—DLG4—Parkinson's disease	0.000747	0.00201	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—ABL1—Parkinson's disease	0.00074	0.00199	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—ABL1—Parkinson's disease	0.00074	0.00199	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ABL1—Parkinson's disease	0.000736	0.00198	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HSPA8—Parkinson's disease	0.000732	0.00197	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HSPA8—Parkinson's disease	0.000732	0.00197	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—GRIN2B—Parkinson's disease	0.000731	0.00197	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—DLG4—Parkinson's disease	0.000715	0.00193	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—HSPA8—Parkinson's disease	0.000706	0.0019	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HSPA8—Parkinson's disease	0.000706	0.0019	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—GRIN2B—Parkinson's disease	0.000699	0.00188	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—HSPA8—Parkinson's disease	0.000695	0.00187	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—DLG4—Parkinson's disease	0.000687	0.00185	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—DLG4—Parkinson's disease	0.000687	0.00185	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—GRIN2B—Parkinson's disease	0.000671	0.00181	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—GRIN2B—Parkinson's disease	0.000671	0.00181	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—DLG4—Parkinson's disease	0.000662	0.00178	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—DLG4—Parkinson's disease	0.000662	0.00178	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.000653	0.00176	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—GRIN2B—Parkinson's disease	0.000647	0.00174	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—GRIN2B—Parkinson's disease	0.000647	0.00174	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.000638	0.00172	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—INS—Parkinson's disease	0.000597	0.00161	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ABL1—Parkinson's disease	0.000596	0.0016	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ABL1—Parkinson's disease	0.00057	0.00153	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ABL1—Parkinson's disease	0.000547	0.00147	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ABL1—Parkinson's disease	0.000547	0.00147	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—INS—Parkinson's disease	0.000532	0.00143	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ABL1—Parkinson's disease	0.000528	0.00142	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ABL1—Parkinson's disease	0.000528	0.00142	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.00052	0.0014	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.000496	0.00134	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—INS—Parkinson's disease	0.000487	0.00131	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.000466	0.00125	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00046	0.00124	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000459	0.00124	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.000455	0.00123	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—INS—Parkinson's disease	0.000394	0.00106	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—INS—Parkinson's disease	0.000376	0.00101	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ABL1—Parkinson's disease	0.000371	0.000999	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—Parkinson's disease	0.000366	0.000985	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—INS—Parkinson's disease	0.000362	0.000974	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—INS—Parkinson's disease	0.000362	0.000974	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—INS—Parkinson's disease	0.000349	0.000939	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—INS—Parkinson's disease	0.000349	0.000939	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000334	0.000899	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—Parkinson's disease	0.000326	0.000877	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—Parkinson's disease	0.000323	0.000871	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6—Parkinson's disease	0.000298	0.000803	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—Parkinson's disease	0.000288	0.000776	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000269	0.000726	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—Parkinson's disease	0.000264	0.00071	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6—Parkinson's disease	0.000261	0.000703	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—INS—Parkinson's disease	0.000245	0.00066	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—Parkinson's disease	0.000241	0.000649	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—Parkinson's disease	0.000233	0.000626	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—Parkinson's disease	0.000231	0.000621	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6—Parkinson's disease	0.000221	0.000596	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—Parkinson's disease	0.000221	0.000596	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—Parkinson's disease	0.000214	0.000575	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—Parkinson's disease	0.000214	0.000575	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TNF—Parkinson's disease	0.000213	0.000574	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—Parkinson's disease	0.000213	0.000573	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TNF—Parkinson's disease	0.000204	0.000549	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—Parkinson's disease	0.000196	0.000527	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—Parkinson's disease	0.000196	0.000527	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—Parkinson's disease	0.000189	0.000509	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TNF—Parkinson's disease	0.000189	0.000509	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6—Parkinson's disease	0.000172	0.000463	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—Parkinson's disease	0.000164	0.000443	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6—Parkinson's disease	0.000158	0.000426	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—Parkinson's disease	0.000158	0.000426	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—Parkinson's disease	0.000152	0.00041	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—Parkinson's disease	0.000152	0.00041	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—Parkinson's disease	0.00015	0.000404	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—Parkinson's disease	0.000133	0.000358	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—Parkinson's disease	0.000107	0.000289	CbGpPWpGaD
